Highlighting immunotherapy research from 2016, a white paper from the Institute for Clinical Immuno-Oncology founded by the Association of Community Cancer Centers isolated emerging policy issues and challenges that may impact the future of immune-oncology in practice.
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
